Erwin Blomsma | Chief Executive Officer
ViroVet

Erwin Blomsma holds a Master’s degree in Bioscience Engineering and a Ph.D. in Applied Biological Sciences (1995) from KU Leuven in Belgium.  After post-doctoral studies at UCB he started his career at Janssen Pharmaceutica in 1996 in the Chemical Process Technology Group.  In 2000 he co-founded Crystallics, a spin-off from the University of Leiden (NL) specializing in preformulation research.  Crystallics was absorbed by Avantium Technologies in 2001, and he was appointed Chief Operating Officer there in 2004, playing a key role in making the company cash-positive at that time. 
In 2007, Dr Blomsma joined Dr Stefaan Wera and Professor Johan Neyts as co-founder and CEO of Okapi Sciences. He became Vice President of Aratana Therapeutics after the acquisition of Okapi Sciences by Aratana in 2014.  In July 2015 he co-founded spinoff ViroVet.  Erwin Blomsma is the active CEO of ViroVet, an animal health company focused on livestock. Furthermore, Erwin Blomsma is the current vice-chairman of FlandersBio and a director at Benno Therapeutics and Leuven MindGate.